Literature DB >> 2654943

Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.

S Ikehara1, R Yasumizu, M Inaba, S Izui, K Hayakawa, K Sekita, J Toki, K Sugiura, H Iwai, T Nakamura.   

Abstract

Long-term effects of allogeneic bone marrow transplantation (ABMT) across major histocompatibility complex barriers were studied in (NZB x NZW)F1 (B/W), BXSB, and MRL/Mr-lpr-lpr (MRL/lpr) mice with established autoimmune disease at the time of ABMT. In the BXSB or B/W mice, ABMT cured all aspects of autoimmune disease. Glomerular damage, revealed by histological study was dramatically improved. Serological abnormalities and immunologic functions also were normalized. Correction of autoimmune disease and advanced renal disease in BXSB and B/W mice regularly lasted greater than 5-6 mo and even 1 yr after ABMT. In the MRL/lpr mice, however, autoimmune and renal disease at first improved but then recurred after ABMT, apparently because of intolerance of mice for high doses of irradiation and a high degree of resistance of recipient stem cells to irradiation. In this model, H-2 typing revealed that by the time of relapse, immunocompetent cells of the chimeric mice had been replaced by host (MRL/lpr; H-2k) cells. B220+ Ly-1+ cells, present in increased numbers in untreated MRL/lpr mice, initially returned to normal levels after ABMT but then reappeared in the MRL/lpr mice that had received marrow from donors having few such lymphocytes. Thus, our results show that MRL/lpr mice possess abnormal radioresistant stem cells and provide impressive evidence that the origin of autoimmune diseases in this strain, as in the several other strains studied, residues in abnormalities present in stem cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654943      PMCID: PMC287120          DOI: 10.1073/pnas.86.9.3306

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Expression of autoimmunity by NZB/NZW marrow.

Authors:  M Akizuki; J P Reeves; A D Steinberg
Journal:  Clin Immunol Immunopathol       Date:  1978-07

2.  Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA/2 mice.

Authors:  H Jyonouchi; P W Kincade; R A Good; G Fernandes
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

3.  One-way occurrence of graft-versus-host disease in bone marrow chimaeras between congenic MRL mice.

Authors:  M Fujiwara; A Kariyone
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

4.  Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset.

Authors:  H C Morse; W F Davidson; R A Yetter; E D Murphy; J B Roths; R L Coffman
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  Rationale for bone marrow transplantation in the treatment of autoimmune diseases.

Authors:  S Ikehara; R A Good; T Nakamura; K Sekita; S Inoue; M M Oo; E Muso; K Ogawa; Y Hamashima
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

6.  Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.

Authors:  N Maruyama; F Furukawa; Y Nakai; Y Sasaki; K Ohta; S Ozaki; S Hirose; T Shirai
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

7.  The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice.

Authors:  D L Perkins; J Michaelson; A Marshak-Rothstein
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

8.  Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice.

Authors:  J I Morton; B V Siegel
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

9.  Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus.

Authors:  S Izui; P J McConahey; A N Theofilopoulos; F J Dixon
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

10.  The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.

Authors:  K Hayakawa; R R Hardy; D R Parks; L A Herzenberg
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Stem cell transplantation for autoimmune diseases.

Authors:  J Moore; P Brooks
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  New strategies for BMT and organ transplantation.

Authors:  Susumu Ikehara
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells.

Authors:  S Ikehara; M Kawamura; F Takao; M Inaba; R Yasumizu; S Than; H Hisha; K Sugiura; Y Koide; T O Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  Nonmyeloablative allogeneic bone marrow transplantation of a child with systemic autoimmune disease and lung vasculitis.

Authors:  Olcay Y Jones; Richard A Cahill
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  Haematopoietic cell transfers between C57BL/6 mice differing at the lpr or gld locus.

Authors:  E M Montecino-Rodriguez; F Loor
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

6.  Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

Authors:  Dominique Farge; Myriam Labopin; Alan Tyndall; Athanasios Fassas; Gian Luigi Mancardi; Jaap Van Laar; Jian Ouyang; Tomas Kozak; John Moore; Ina Kötter; Virginie Chesnel; Alberto Marmont; Alois Gratwohl; Riccardo Saccardi
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

7.  Reciprocal haematopoietic cell transfers between C57BL/6 mice differing at the lpr locus.

Authors:  E M Montecino-Rodriguez; F Loor
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

8.  Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; O Abramsky; A Ben-Nun; S Slavin
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

9.  Analyses of T-cell differentiation from hemopoietic stem cells in the G0 phase by an in vitro method.

Authors:  J Toki; T Kumamoto; H Ogata; M Kawamura; M Fukumoto; Y Yamamoto; S Than; M Inaba; Y Himeno
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

Review 10.  [Immunoablation followed by autologous stem cell transplantation in lupus: a clinical update].

Authors:  T Alexander; R Arnold; F Hiepe
Journal:  Z Rheumatol       Date:  2009-05       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.